70 institutions reported holding $52.7M of CUE BIOPHARMA (CUE) in SEC 13F filings for 2026-06-30. Largest institutional holders: Bleichroeder LP ($11.7M), Driehaus Capital Management LLC ($9.2M), VANGUARD GROUP INC ($5.9M), Ikarian Capital, LLC ($3.3M), TFG Asset Management GP Ltd ($3.0M). Source: SEC Form 13F.
来源:SEC 13F 申报文件 · 截至 2026-06-30